What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Concord Biotech Limited IPO?

Based on the upper price band of ₹741 and current GMP of ₹125, the estimated listing price is ₹866 (approx. 16.9% gain).

What is the expected profit per lot for Concord Biotech Limited IPO?

With a lot size of 20 shares and current GMP of ₹125, expected profit per retail application lot is approximately ₹2,500.

IPO GreyPremiumLIVE

Grey Market Intelligence

Concord Biotech Limited

ListedMainboard

Pharmaceuticals & Biotechnology · NSE / BSE

Incorporated in 1984, Concord Biotech Limited is an India-based biopharmaceutical company and a leading global developer and manufacturer of fermentation-based APIs, specializing in immunosuppressants and oncology. The company has a strong global presence, supplying products to over 70 countries including the USA, India, Europe, and Japan. Concord Biotech manufactures Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Starting with a single product, the company has expanded to offer a broad spectrum of biopharma solutions, establishing itself as a key player in the global API market.

Price Band

₹705 – ₹741

Issue Size

₹1551 Cr

Lot Size

20 shares

GMP

₹125

+16.9%

Est. Listing

₹866

at current GMP

Subscribed

26.13x

overall

Open

4 Aug 2023

8 Aug 2023

Allotment

14 Aug 2023

Refund

15 Aug 2023

Demat Credit

16 Aug 2023

Listing

18 Aug 2023

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Concord Biotech Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹125+16.9%

Issue Price (Upper)

₹741

Band: ₹705 – ₹741

Estimated Listing Price

₹866

Upper price + GMP

Lot Size

20 shares

Min investment ₹14,820

Estimated Profit / Lot

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹125	16.9%	₹866
30 Oct 2026	+₹125	16.9%	₹866
29 Oct 2026	+₹113	15.2%	₹854

About Concord Biotech Limited Public Issue & Market Profile

Concord Biotech Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Biotechnology sector with an aggregate issue size of ₹1,551 Crores. The shares are offered at a price band of ₹705 to ₹741 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Public Issue & Pricing Context:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Basis of Allotment & Listing Timeline:

Following the close of bidding on 2023-08-08, the basis of allotment is scheduled to be finalized on 2023-08-14. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Concord Biotech Limited IPO GMP today?

The latest grey market premium for Concord Biotech Limited IPO is ₹125, which indicates an expected listing price of ₹866.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.